Extract of ganoderma formosanum mycelium as a highly potent tyrosinase inhibitor

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hsu, Kai Di ^a   Chen, Hong Jhang ^a   Wang, Chi Shin ^a   Lum, Chi Chin ^a   Wu, Shu Pei ^a   Lin, Shin Ping ^a   Cheng, Kuan Chen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; MONOPHENOL MONOOXYGENASE; ZEBRAFISH PROTEIN;

ANIMAL; ANIMAL MODEL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GANODERMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MYCELIUM; SKIN PIGMENTATION; ZEBRA FISH;

ANIMALS; BIOLOGICAL PRODUCTS; GANODERMA; GENE EXPRESSION REGULATION; MODELS, ANIMAL; MONOPHENOL MONOOXYGENASE; MYCELIUM; SKIN PIGMENTATION; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84987678645     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32854     Document Type: Article

References (42)

1. Slominski, A., Tobin, D. J., Shibahara, S. & Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 84, 1155-1228, doi: 10.1152/physrev.00044.2003 (2004).
2. Hu, S. T. , Zheng, Z. P. , Zhang, X. C., Chen, F. & Wang, M. F. Oxyresveratrol and trans-dihydromorin from the twigs of Cudrania tricuspidata as hypopigmenting agents against melanogenesis. J Funct Foods 13, 375-383, doi: 10.1016/j.jf.2015.01.010 (2015).
3. Brenner, M. & Hearing, V. J. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 84, 539-549, doi: 10.1111/j.1751-1097.2007.00226.x (2008).
4. Yoon, N. Y., Eom, T. K., Kim, M. M. & Kim, S. K. Inhibitory Efect of Phlorotannins Isolated from Ecklonia cava on Mushroom Tyrosinase Activity and Melanin Formation in Mouse B16F10 Melanoma Cells. J Agr Food Chem. 57, 4124-4129, doi: 10.1021/ jf900006f (2009).
5. Choi, T. Y. et al. Zebrafsh as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigm Cell Res. 20, 120-127, doi: 10.1111/j.1600-0749.2007.00365.x (2007).
6. Kalahroudi, V. G. et al. Two Novel Tyrosinase (TYR) Gene Mutations with Pathogenic Impact on Oculocutaneous Albinism Type 1 (OCA1). Plos One 9, doi: ARTN e10665610.1371/journal.pone 0106656 (2014).
7. Zhang, L. et al. Methyl lucidenate F isolated from the ethanol-soluble-acidic components of Ganoderma lucidum is a novel tyrosinase inhibitor. Biotechnol Bioproc E 16, 457-461, doi: 10.1007/s12257-010-0345-z (2011).
8. Ohbayashi, N. & Fukuda, M. Role of Rab family GTPases and their efectors in melanosomal logistics. J Biochem. 151, 343-351, doi: 10.1093/jb/mvs009 (2012).
9. Iozumi, K., Hoganson, G. E., Pennella, R., Everett, M. A. & Fuller, B. B. Role of Tyrosinase as the Determinant of Pigmentation in Cultured Human Melanocytes. J Invest Dermatol. 100, 806-811, doi: 10.1111/1523-1747.ep12476630 (1993).
10. Deepalakshmi, K., Mirunalini, S., Krishnaveni, M. & Arulmozhi, V. In vitro and in vivo antioxidant potentials of an ethanolic extract of Ganoderma lucidum in rat mammary carcinogenesis. Chin J Nat Medicines 11, 621-627, doi: 10.3724/Sp.J.1009.2013.00621 (2013).
11. Tan, N. Z. et al. Ganoderma lucidum ReishiMax restored aging-related changes in expressions of multiple gene pathways in normal aging mice. Faseb J 28 (2014).
12. Tun, T. C. & Tou, C. Ganoderma formosanum Sp-Nov on Formosan Sweet Gum in Taiwan. T Brit Mycol Soc. 82, 731-733 (1984).
13. Wang, C. L., Lu, C. Y. , Hsueh, Y. C., Liu, W. H. & Chen, C. J. Activation of antitumor immune responses by Ganoderma formosanum polysaccharides in tumor-bearing mice. Appl Microbiol Biot. 98, 9389-9398, doi: 10.1007/s00253-014-6027-6 (2014).
14. Wang, C. L. et al. Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors. Bmc Complem Altern M 12, doi: Artn 11910.1186/1472-6882-12-119 (2012).
15. Chien, C. C., Tsai, M. L., Chen, C. C., Chang, S. J. & Tseng, C. H. Efects on tyrosinase activity by the extracts of Ganoderma lucidum and related mushrooms. Mycopathologia 166, 117-120, doi: 10.1007/s11046-008-9128-x (2008).
16. Mukaiyama, T. et al. In Animal Cell Technology: Basic & Applied Aspects Vol. 15 Animal Cell Technology: Basic & Applied Aspects (eds Sanetaka, Shirahata et al.) Ch. 42, 273-277 (Springer Netherlands, 2009).
17. Singhania, R. R., Sukumaran, R. K., Patel, A. K., Larroche, C. & Pandey, A. Advancement and comparative profles in the production technologies using solid-state and submerged fermentation for microbial cellulases. Enzyme Microb Tech. 46, 541-549, doi: 10.1016/j.enzmictec.2010.03.010 (2010).
18. Langheinrich, U. Zebrafsh: a new model on the pharmaceutical catwalk. Bioessays 25, 904-912, doi: 10.1002/bies.10326 (2003).
19. Zon, L. I. & Peterson, R. T. In vivo drug discovery in the zebrafsh. Nat Rev Drug Discov. 4, 35-44, doi: 10.1038/nrd1606 (2005).
20. Cheng, K. C. Skin Color in Fish and Humans: Impacts on Science and Society. Zebrafsh 5, 237-242, doi: 10.1089/zeb.2008.0577 (2008).
21. Zhang, C. et al. Tyrosinase inhibitory efects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. J Enzyme Inhib Med Chem. 22, 91-98, doi: 10.1080/14756360600988989 (2007).
22. Wilson, V. G. Growth and diferentiation of HaCaT keratinocytes. Methods Mol Biol. 1195, 33-41, doi: 10.1007/7651-2013-42 (2014).
23. Yoo, Y. S., Yoo, M. A., Song, Y. K. & Byun, S. Y. Regulation of proteins related to melanogenesis by heartwood extract of Morus bombycis using proteome analysis. Biotechnol Bioproc E 12, 662-667 (2007).
24. Ding, H. Y. , Chang, T. S., Shen, H. C. & Tai, S. S. K. Murine tyrosinase Inhibitors from Cynanchum bungei and evaluation of in vitro and in vivo depigmenting activity. Exp Dermatol. 20, 720-724, doi: 10.1111/j.1600-0625.2011.01302.x (2011).
25. Sung, J. H. et al. Antioxidative and Skin-Whitening Efect of an Aqueous Extract of Salicornia herbacea. Biosci Biotech Bioch. 73, 552-556, doi: 10.1271/bbb.80601 (2009).
26. Peterson, R. T., Link, B. A., Dowling, J. E. & Schreiber, S. L. Small molecule developmental screens reveal the logic and timing of vertebrate development. P Natl Acad Sci USA 97, 12965-12969, doi: 10.1073/pnas.97.24.12965 (2000).
27. Karlsson, J., von Hofsten, J. & Olsson, P. E. Generating transparent zebrafsh: A refned method to improve detection of gene expression during embryonic development. Mar Biotechnol. 3, 522-527, doi: 10.1007/s1012601-0053-4 (2001).
28. Chang, C. J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 6, doi: ARTN 748910.1038/ncomms8489 (2015).
29. Bishop, K. S. et al. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114, 56-65, doi: 10.1016/j.phytochem.2015.02.015 (2015).
30. Chang, T. S. An updated review of tyrosinase inhibitors. Int J Mol Sci. 10, 2440-2475, doi: 10.3390/ijms10062440 (2009).
31. Tai, S. S. K., Lin, C. G., Wu, M. H. & Chang, T. S. Evaluation of Depigmenting Activity by 8-Hydroxydaidzein in Mouse B16 Melanoma Cells and Human Volunteers. Int J Mol Sci. 10, 4257-4266, doi: 10.3390/ijms10104257 (2009).
32. Siegrist, W. & Eberle, A. N. In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Analytical Biochemistry 159, 191-197, doi: 10.1016/0003-2697(86)90327-1 (1986).
33. Shin, J. T. & Fishman, M. C. From zebrafsh to human: Modular medical models. Annu Rev Genom Hum G 3, 311-340, doi: 10.1146/ annurev.genom.3.031402.131506 (2002).
34. Briggs, J. P. The zebrafsh: A new model organism for integrative physiology. Am J Physiol-Reg I. 282, R3-R9 (2002).
35. Chen, W. C. et al. Discovery of Highly Potent Tyrosinase Inhibitor, T1, with Signifcant Anti-Melanogenesis Ability by zebrafsh in vivo Assay and Computational Molecular Modeling. Sci Rep-Uk 5, doi: ARTN 799510.1038/srep07995 (2015).
36. Camp, E. & Lardelli, M. Tyrosinase gene expression in zebrafish embryos. Dev Genes Evol. 211, 150-153, doi: 10.1007/ s004270000125 (2001).
37. Wu, S. Y. S. et al. 4-(Phenylsulfanyl)butan-2-One Suppresses Melanin Synthesis and Melanosome Maturation In Vitro and In Vivo . Int J Mol Sci. 16, 20240-20257, doi: 10.3390/ijms160920240 (2015).
38. Scholz, S. Zebrafsh embryos as an alternative model for screening of drug-induced organ toxicity. Arch Toxicol. 87, 767-769, doi: 10.1007/s00204-013-1044-2 (2013).
39. Germanas, J. P. , Wang, S. G., Miner, A., Hao, W. & Ready, J. M. Discovery of small-molecule inhibitors of tyrosinase. Bioorg Med Chem Lett. 17, 6871-6875, doi: 10.1016/j.bmcl.2007.10.014 (2007).
40. Likhitwitayawuid, K. & Sritularak, B. A new dimeric stilbene with tyrosinase inhibitiory activity from Artocarpus gomezianus. J Nat Prod. 64, 1457-1459, doi: 10.1021/np0101806 (2001).
41. Kim, J. H. et al. Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model. J Invest Dermatol. 128, 1227-1235, doi: 10.1038/sj.jid.5701177 (2008).
42. Lee, S. J. et al. LPA(1) is essential for lymphatic vessel development in zebrafsh. Faseb J 22, 3706-3715, doi: 10.1096/f.08-106088 (2008).